Climb Bio, Inc. (CLYM) Financials

CLYM Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 152.4 million 4.3 million
Dec. 31, 2025 167.7 million 7.3 million
Sept. 30, 2025 182.3 million 5.3 million
June 30, 2025 192.4 million 6.6 million

CLYM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -14.4 million 1.6 million
Dec. 31, 2025 -15.6 million 1.0 million
Sept. 30, 2025 -12.2 million 4.0 million
June 30, 2025 -11.2 million 1.0 million

CLYM Net Income

No data available :(

CLYM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 109.6 million - 216000
Dec. 31, 2025 101.1 million - 285000
Sept. 30, 2025 86.9 million - 580000
June 30, 2025 84.7 million - 639000

CLYM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 68.2 million
Dec. 31, 2025 67.4 million
Sept. 30, 2025 68.0 million
June 30, 2025 67.6 million

CLYM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 9.3 million 5.8 million -
Dec. 31, 2025 - 13.7 million 5.5 million -
Sept. 30, 2025 109000 9.1 million 5.8 million -
June 30, 2025 77000 6.6 million 4.1 million -

CLYM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 38000
Dec. 31, 2025 - 30000
Sept. 30, 2025 - 29000
June 30, 2025 - 38000

CLYM

Price: $11.12

52 week price:
1.16
12.48

Earnings Per Share: -0.77 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 711.8 million

Links: